Abstract
Plant molecular pharming has emerged as a reliable platform for recombinant protein expression providing a safe and low-cost alternative to bacterial and mammalian cells-based systems. Simultaneously, plant viruses have evolved from pathogens to molecular tools for recombinant protein expression, chimaeric viral vaccine production, and lately, as nanoagents for drug delivery. This review summarizes the genesis of viral vectors and agroinfection, the development of non-enveloped viruses for various biotechnological applications, and the on-going research on enveloped plant viruses.
Highlights
Reviewed by: George Peter Lomonossoff, John Innes Centre (JIC), United Kingdom Zhenghe Li, Zhejiang University, China Ulrich Commandeur, RWTH Aachen University, Germany
This review summarizes the genesis of viral vectors and agroinfection, the development of non-enveloped viruses for various biotechnological applications, and the on-going research on enveloped plant viruses
This pathogen is known as tobacco mosaic virus (TMV) and is one of the prominent viruses in plant molecular pharming
Summary
Reviewed by: George Peter Lomonossoff, John Innes Centre (JIC), United Kingdom Zhenghe Li, Zhejiang University, China Ulrich Commandeur, RWTH Aachen University, Germany.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
